Kohan, D. E., Fioretto, P., Tang, W., & List, J. F. (2014). Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control. Nature Publishing Group.
Chicago Style CitationKohan, Donald E., Paola Fioretto, Weihua Tang, and James F. List. Long-term Study of Patients With Type 2 Diabetes and Moderate Renal Impairment Shows That Dapagliflozin Reduces Weight and Blood Pressure but Does Not Improve Glycemic Control. Nature Publishing Group, 2014.
MLA CitationKohan, Donald E., Paola Fioretto, Weihua Tang, and James F. List. Long-term Study of Patients With Type 2 Diabetes and Moderate Renal Impairment Shows That Dapagliflozin Reduces Weight and Blood Pressure but Does Not Improve Glycemic Control. Nature Publishing Group, 2014.